Regarding Sirt1, it has been studied strongly in the context of neurodegenerative diseases and Selisistat [EX-527 (1), Figure 1] is a potent and selective Sirt1 inhibitor that was undergoing clinical testing in Huntington's disease (20). The gene discussed is SIRT1; the disease is juvenile Huntington disease.